Kings Path Partners LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2030974 SUGAR LAND, TX

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$884

New position

Shares Held

7

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#2,251

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kings Path Partners LLC holds $684,839 across 5 Drug Manufacturers - General names. GILD ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,608	$335,128
2	JNJ	Johnson & Johnson	1,099	$279,113
3	PFE	Pfizer Inc	2,850	$68,628
4	AMGN	Amgen Inc	3	$1,086
5	GILD	Gilead Sciences, Inc. This page	7	$884

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$884	7	—	Shares	Sole	2026-07-14
No filing history on record for this holder in this stock.